{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:26:47Z","timestamp":1793748407544,"version":"4.6.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00467-026-07432-1","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T13:03:26Z","timestamp":1782306206000},"page":"4107-4115","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk stratification guided treatment and outcomes of pediatric membranous nephropathy"],"prefix":"10.1007","volume":"41","author":[{"given":"Umer","family":"Manzoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1386-476X","authenticated-orcid":false,"given":"Irshad Ali","family":"Bajeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabeeta","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habib","family":"Qaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Hashmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"7432_CR1","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.ekir.2025.03.027","volume":"10","author":"LP Laurin","year":"2025","unstructured":"Laurin LP, Helmuth M, Almaani S, Ayoub I, Chen DP, Villegas LA et al (2025) Risk factors for disease progression for adults and children with membranous nephropathy in the Cure Glomerulonephropathy Network (CureGN). Kidney Int Rep 10:1917\u20131928. https:\/\/doi.org\/10.1016\/j.ekir.2025.03.027","journal-title":"Kidney Int Rep"},{"key":"7432_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00467-019-04425-1","volume":"36","author":"L Safar-Boueri","year":"2021","unstructured":"Safar-Boueri L, Piya A, Beck LH, Ayalon R (2021) Membranous nephropathy: diagnosis, treatment, and monitoring in the post-PLA2R era. Pediatr Nephrol 36:19\u201330. https:\/\/doi.org\/10.1007\/s00467-019-04425-1","journal-title":"Pediatr Nephrol"},{"key":"7432_CR3","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1093\/ndt\/gfr221","volume":"27","author":"M Mubarak","year":"2012","unstructured":"Mubarak M, Kazi JI, Lanewala A, Hashmi S, Akhter F (2012) Pathology of idiopathic nephrotic syndrome in children: are the adolescents different from young children? Nephrol Dial Transplant 27:722\u2013726. https:\/\/doi.org\/10.1093\/ndt\/gfr221","journal-title":"Nephrol Dial Transplant"},{"key":"7432_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.962502","volume":"13","author":"G Huang","year":"2022","unstructured":"Huang G, Liu F, Yu L, Wang J, Chen J, Mao J (2022) Pediatric membranous nephropathy: in the novel antigens era. Front Immunol 13:962502. https:\/\/doi.org\/10.3389\/fimmu.2022.962502","journal-title":"Front Immunol"},{"key":"7432_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1053\/j.akdh.2024.04.004","volume":"31","author":"J Bharati","year":"2024","unstructured":"Bharati J, Waguespack DR, Beck LH (2024) Membranous nephropathy: updates on management. Adv Kidney Dis Health 31:299\u2013308. https:\/\/doi.org\/10.1053\/j.akdh.2024.04.004","journal-title":"Adv Kidney Dis Health"},{"key":"7432_CR6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00467-008-1005-9","volume":"24","author":"RP Valentini","year":"2009","unstructured":"Valentini RP, Mattoo TK, Kapur G, Imam A (2009) Membranous glomerulonephritis: treatment response and outcome in children. Pediatr Nephrol 24:301\u2013308. https:\/\/doi.org\/10.1007\/s00467-008-1005-9","journal-title":"Pediatr Nephrol"},{"key":"7432_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-8-11","volume":"8","author":"A Chen","year":"2007","unstructured":"Chen A, Frank R, Vento S, Crosby V, Chandra M, Gauthier B et al (2007) Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome. BMC Nephrol 8:11. https:\/\/doi.org\/10.1186\/1471-2369-8-11","journal-title":"BMC Nephrol"},{"key":"7432_CR8","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s00467-006-0246-8","volume":"21","author":"BH Lee","year":"2006","unstructured":"Lee BH, Cho HY, Kang HG, Ha IS, Cheong HI, Moon KC et al (2006) Idiopathic membranous nephropathy in children. Pediatr Nephrol 21:1707\u20131715. https:\/\/doi.org\/10.1007\/s00467-006-0246-8","journal-title":"Pediatr Nephrol"},{"key":"7432_CR9","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"BH Rovin","year":"2021","unstructured":"Rovin BH, Adler SG, Barratt J, Bridoux F, Burdge KA, Chan TM et al (2021) KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int 100:S1-276. https:\/\/doi.org\/10.1016\/j.kint.2021.05.021","journal-title":"Kidney Int"},{"key":"7432_CR10","doi-asserted-by":"publisher","DOI":"10.1590\/2175-8239-jbn-2025-0228en","volume":"48","author":"K Bashir","year":"2026","unstructured":"Bashir K, Asghar MR, Saleem N, Shahzil M, Riaz A, Hashmi MN et al (2026) Anti-PLA2R antibody reduction as a predictor of treatment response in primary membranous nephropathy: a retrospective study. Braz J Nephrol 48:e20250228. https:\/\/doi.org\/10.1590\/2175-8239-jbn-2025-0228en","journal-title":"Braz J Nephrol"},{"key":"7432_CR11","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s00467-020-04798-8","volume":"36","author":"R Ramachandran","year":"2021","unstructured":"Ramachandran R, Nayak S, Kumar V, Kumar A, Agrawal N, Bansal R et al (2021) Primary membranous nephropathy in children and adolescents: a single-centre report from South Asia. Pediatr Nephrol 36:1217\u20131226. https:\/\/doi.org\/10.1007\/s00467-020-04798-8","journal-title":"Pediatr Nephrol"},{"key":"7432_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.53778\/pjkd38101","volume":"3","author":"AAA Lanewala","year":"2021","unstructured":"Lanewala AAA, Hashmi S, Tresa V, Khatri S, Bajeer IA, Ehsan A et al (2021) Consensus guidelines for the treatment of nephrotic syndrome in children of Pakistan: endorsed by Pakistan Pediatric Association- Nephrology Group. Pakistan J Kidney Dis 3:1\u201320. https:\/\/doi.org\/10.53778\/pjkd38101","journal-title":"Pakistan J Kidney Dis"},{"key":"7432_CR13","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/ndt\/gfad227","volume":"39","author":"S Sethi","year":"2024","unstructured":"Sethi S, Fervenza FC (2024) Membranous nephropathy\u2014diagnosis and identification of target antigens. Nephrol Dial Transplant 39:600\u2013606. https:\/\/doi.org\/10.1093\/ndt\/gfad227","journal-title":"Nephrol Dial Transplant"},{"key":"7432_CR14","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1007\/s40620-025-02224-6","volume":"38","author":"K Sridharan","year":"2025","unstructured":"Sridharan K, Gopal B, Wilson S, Pham A, Hutton H (2025) Obinutuzumab in rituximab-resistant and recurrent membranous nephropathy: a case-series. J Nephrol 38:1809\u20131818. https:\/\/doi.org\/10.1007\/s40620-025-02224-6","journal-title":"J Nephrol"},{"key":"7432_CR15","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/ckj\/sfw047","volume":"9","author":"F Becherucci","year":"2016","unstructured":"Becherucci F, Roperto RM, Materassi M, Romagnani P (2016) Chronic kidney disease in children. Clin Kidney J 9:583\u2013591. https:\/\/doi.org\/10.1093\/ckj\/sfw047","journal-title":"Clin Kidney J"},{"key":"7432_CR16","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2215\/CJN.11761116","volume":"12","author":"WG Couser","year":"2017","unstructured":"Couser WG (2017) Primary membranous nephropathy. Clin J Am Soc Nephrol 12:983\u2013997. https:\/\/doi.org\/10.2215\/CJN.11761116","journal-title":"Clin J Am Soc Nephrol"},{"key":"7432_CR17","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1007\/s00467-022-05503-7","volume":"37","author":"P Miller","year":"2022","unstructured":"Miller P, Lei L, Charu V, Higgins J, Troxell M, Kambham N (2022) Clinicopathologic features of non-lupus membranous nephropathy in a pediatric population. Pediatr Nephrol 37:3127\u20133137. https:\/\/doi.org\/10.1007\/s00467-022-05503-7","journal-title":"Pediatr Nephrol"},{"key":"7432_CR18","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/modpathol.2015.1","volume":"28","author":"NC Messias","year":"2015","unstructured":"Messias NC, Walker PD, Larsen CP (2015) Paraffin immunofluorescence in the renal pathology laboratory: more than a salvage technique. Mod Pathol 28:854\u2013860. https:\/\/doi.org\/10.1038\/modpathol.2015.1","journal-title":"Mod Pathol"},{"key":"7432_CR19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.kint.2023.10.035","volume":"105","author":"AD Kistler","year":"2024","unstructured":"Kistler AD, Salant DJ (2024) Complement activation and effector pathways in membranous nephropathy. Kidney Int 105:473\u2013483. https:\/\/doi.org\/10.1016\/j.kint.2023.10.035","journal-title":"Kidney Int"},{"key":"7432_CR20","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1016\/j.ekir.2023.08.018","volume":"8","author":"AM Kouri","year":"2023","unstructured":"Kouri AM, Caza TN, Beck LH, Misurac JM, Evans MD, Phillips CL et al (2023) Clinical and histopathologic characteristics of pediatric patients with primary membranous nephropathy. Kidney Int Rep 8:2368\u20132375. https:\/\/doi.org\/10.1016\/j.ekir.2023.08.018","journal-title":"Kidney Int Rep"},{"key":"7432_CR21","doi-asserted-by":"publisher","first-page":"432","DOI":"10.4103\/ijn.ijn_228_22","volume":"33","author":"R Deepthi","year":"2023","unstructured":"Deepthi R, George S, Mathew G, Roy S, Bindra M, Rebekah G et al (2023) The clinical profile and long-term outcome of children with membranous nephropathy, and the evaluation of anti-phospholipase A2 receptor antibody immunohistochemistry in kidney biopsy. Indian J Nephrol 33:432\u2013439. https:\/\/doi.org\/10.4103\/ijn.ijn_228_22","journal-title":"Indian J Nephrol"},{"key":"7432_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1056\/NEJMoa1814427","volume":"381","author":"FC Fervenza","year":"2019","unstructured":"Fervenza FC, Appel GB, Barbour SJ, Rovin BH, Lafayette RA, Aslam N et al (2019) Rituximab or cyclosporine in the treatment of membranous nephropathy. N Engl J Med 381:36\u201346. https:\/\/doi.org\/10.1056\/NEJMoa1814427","journal-title":"N Engl J Med"},{"key":"7432_CR23","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.kint.2020.10.014","volume":"99","author":"G Fern\u00e1ndez-Ju\u00e1rez","year":"2021","unstructured":"Fern\u00e1ndez-Ju\u00e1rez G, Rojas-Rivera J, Logt AEVD, Justino J, Sevillano A, Caravaca-Font\u00e1n F et al (2021) The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy. Kidney Int 99:986\u2013998. https:\/\/doi.org\/10.1016\/j.kint.2020.10.014","journal-title":"Kidney Int"},{"key":"7432_CR24","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00467-018-3923-5","volume":"33","author":"R Malatesta-Muncher","year":"2018","unstructured":"Malatesta-Muncher R, Eldin KW, Beck LH, Michael M (2018) Idiopathic membranous nephropathy in children treated with rituximab: report of two cases. Pediatr Nephrol 33:1089\u20131092. https:\/\/doi.org\/10.1007\/s00467-018-3923-5","journal-title":"Pediatr Nephrol"},{"key":"7432_CR25","doi-asserted-by":"publisher","first-page":"sfae113","DOI":"10.1093\/ckj\/sfae113","volume":"17","author":"S Nayak","year":"2024","unstructured":"Nayak S, Chauhan P, Jha V, Ramachandran R, Bose B (2024) Outcomes of primary membranous nephropathy refractory to immunosuppressants. Clin Kidney J 17:sfae113. https:\/\/doi.org\/10.1093\/ckj\/sfae113","journal-title":"Clin Kidney J"},{"key":"7432_CR26","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s40620-020-00816-y","volume":"34","author":"R Wang","year":"2021","unstructured":"Wang R, Wang M, Xia Z, Gao C, Shi Z, Fang X et al (2021) Long-term renal survival and related risk factors for primary membranous nephropathy in Chinese children: a retrospective analysis of 217 cases. J Nephrol 34:589\u2013596. https:\/\/doi.org\/10.1007\/s40620-020-00816-y","journal-title":"J Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07432-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-026-07432-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07432-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:03:34Z","timestamp":1793747014000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-026-07432-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["7432"],"URL":"https:\/\/doi.org\/10.1007\/s00467-026-07432-1","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"16 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical review committee of Sindh Institute of Urology and Transplantation approved the study with number ERC# SIUT-ERC-2024\/A-510.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent from the study participants was waived due to retrospective chart review.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No direct or indirect interests to declare.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Figure\u00a0\n                      \n                      and\n                      \n                      were generated through ChatGPT 5.2.","order":4,"name":"Ethics","label":"Assistance of artificial intelligence","group":{"name":"EthicsHeading","label":"Declarations"}}]}}